Gut Permeability Assessment in Celiac and Gluten Sensitive Children
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02690532|
Recruitment Status : Completed
First Posted : February 24, 2016
Last Update Posted : August 15, 2018
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||The Role of Gut Permeability in Developing Celiac Disease and Non-Celiac Gluten Sensitivity|
|Study Start Date :||March 2016|
|Actual Primary Completion Date :||July 1, 2018|
|Actual Study Completion Date :||August 1, 2018|
High risk group
Children who are at high risk for developing celiac disease (siblings diagnosed with celiac disease).
Children who are self-diagnosed with non-celiac gluten sensitivity.
Healthy control group (matched for age and gender).
- Gut Permeability [ Time Frame: Baseline ]Assess the effect of gluten on gut permeability in children at high risk of developing celiac disease or gluten sensitivity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02690532
|United States, Minnesota|
|Mayo Clinic in Rochester|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Imad Absah, MD||Mayo Clinic|